| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3892/IJMM.1.2.491 |
| P698 | PubMed publication ID | 9852255 |
| P50 | author | Ingo Müller | Q40174741 |
| P2093 | author name string | D Niethammer | |
| G Bruchelt | |||
| P433 | issue | 2 | |
| P921 | main subject | cytotoxicity | Q246181 |
| chemotherapy | Q974135 | ||
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 491-494 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | International Journal of Molecular Medicine | Q6051492 |
| P1476 | title | Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review) | |
| P478 | volume | 1 |
| Q34458534 | A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles |
| Q42429579 | A novel quinone-based derivative (DTNQ-Pro) induces apoptotic death via modulation of heat shock protein expression in Caco-2 cells |
| Q36999926 | Antioxidants as potential therapeutics for lung fibrosis |
| Q35671428 | Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: the role of glutathione |
| Q89314557 | Combined Treatments of Magnetic Intra-Lysosomal Hyperthermia with Doxorubicin Promotes Synergistic Anti-Tumoral Activity |
| Q36342896 | Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models |
| Q33463362 | Comparative genome-wide screening identifies a conserved doxorubicin repair network that is diploid specific in Saccharomyces cerevisiae |
| Q44621428 | Cytotoxic iron chelators: characterization of the structure, solution chemistry and redox activity of ligands and iron complexes of the di-2-pyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues |
| Q36509719 | Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia |
| Q37461477 | Doxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell death |
| Q38792745 | Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells |
| Q35981121 | Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release |
| Q73314338 | Fully-automated spectrophotometric method for measurement of antioxidant activity of catalase |
| Q24807351 | Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer |
| Q28475738 | Genipin-induced inhibition of uncoupling protein-2 sensitizes drug-resistant cancer cells to cytotoxic agents |
| Q37351908 | Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia |
| Q35045012 | Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents |
| Q33888575 | Insights in the glycosylation steps during biosynthesis of the antitumor anthracycline cosmomycin: characterization of two glycosyltransferase genes |
| Q36568915 | Iron chelators with topoisomerase-inhibitory activity and their anticancer applications |
| Q57953028 | Lipopolysaccharide augments the in vivo lethal action of doxorubicin against mice via hepatic damage |
| Q43208429 | Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin's lymphoma: single center, 15-year experience |
| Q34540244 | Loss of sphingosine kinase-1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin-induced DNA damage |
| Q36054324 | Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide |
| Q49335475 | Magnesium isoglycyrrhizinate ameliorates doxorubicin-induced acute cardiac and hepatic toxicity via anti-oxidant and anti-apoptotic mechanisms in mice |
| Q37913211 | Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy |
| Q37038711 | Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond |
| Q95797465 | Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells |
| Q38289434 | N-benzoxazol-2-yl-N'-1-(isoquinolin-3-yl-ethylidene)-hydrazine, a novel compound with antitumor activity, induces radicals and dissipation of mitochondrial membrane potential. |
| Q36914910 | Novel ROS-activated agents utilize a tethered amine to selectively target acute myeloid leukemia |
| Q37219532 | Oxidative DNA base damage in MCF-10A breast epithelial cells at clinically achievable concentrations of doxorubicin |
| Q41646063 | Oxidative stress and lipid peroxidation products in cancer progression and therapy |
| Q34696189 | Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs. |
| Q37328360 | Role of oxidative stress in stem, cancer, and cancer stem cells. |
| Q37287624 | Sequencing of type I insulin-like growth factor receptor inhibition affects chemotherapy response in vitro and in vivo |
| Q42923682 | Synergistic inhibition of angiogenesis by artesunate and captopril in vitro and in vivo |
| Q37314629 | TJ-41 Induces Apoptosis and Potentiates the Apoptotic Effects of 5-FU in Breast Cancer Cell Lines |
| Q35697810 | The Hepatoprotective Effect of Haoqin Qingdan Decoction against Liver Injury Induced by a Chemotherapeutic Drug Cyclophosphamide |
| Q33791440 | The differential gene expression profiles between sensitive and resistant breast cancer cells to adriamycin by cDNA microarray |
| Q36134671 | The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer |
| Q37133536 | Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma |
| Q47629982 | VEGFR3 inhibition chemosensitizes lung adenocarcinoma A549 cells in the tumor-associated macrophage microenvironment through upregulation of p53 and PTEN. |
Search more.